T. Rowe Price Associates’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-858,201
| Closed | -$12M | – | 2576 |
|
|
2017
Q4 | $12M | Buy |
858,201
+109,574
| +15% | +$1.53M | ﹤0.01% | 1293 |
|
|
2017
Q3 | $12.6M | Sell |
748,627
-25,400
| -3% | -$427K | ﹤0.01% | 1287 |
|
|
2017
Q2 | $13M | Sell |
774,027
-12,100
| -2% | -$204K | ﹤0.01% | 1270 |
|
|
2017
Q1 | $12.2M | Sell |
786,127
-24,200
| -3% | -$375K | ﹤0.01% | 1292 |
|
|
2016
Q4 | $12.1M | Sell |
810,327
-2,600
| -0.3% | -$38.9K | ﹤0.01% | 1274 |
|
|
2016
Q3 | $10.2M | Sell |
812,927
-288
| -0% | -$3.62K | ﹤0.01% | 1309 |
|
|
2016
Q2 | $7.32M | Sell |
813,215
-8,231
| -1% | -$74.1K | ﹤0.01% | 1341 |
|
|
2016
Q1 | $8.14M | Sell |
821,446
-1,100
| -0.1% | -$10.9K | ﹤0.01% | 1316 |
|
|
2015
Q4 | $9.46M | Sell |
822,546
-6,700
| -0.8% | -$77K | ﹤0.01% | 1298 |
|
|
2015
Q3 | $11.2M | Sell |
829,246
-30,654
| -4% | -$414K | ﹤0.01% | 1285 |
|
|
2015
Q2 | $11.9M | Buy |
859,900
+1,400
| +0.2% | +$19.4K | ﹤0.01% | 1303 |
|
|
2015
Q1 | $12.1M | Buy |
858,500
+8,600
| +1% | +$121K | ﹤0.01% | 1286 |
|
|
2014
Q4 | $11.6M | Hold |
849,900
| – | – | ﹤0.01% | 1280 |
|
|
2014
Q3 | $13M | Sell |
849,900
-900
| -0.1% | -$13.7K | ﹤0.01% | 1238 |
|
|
2014
Q2 | $14.3M | Sell |
850,800
-4,500
| -0.5% | -$75.7K | ﹤0.01% | 1223 |
|
|
2014
Q1 | $17.2M | Buy |
855,300
+1,400
| +0.2% | +$28.1K | ﹤0.01% | 1153 |
|
|
2013
Q4 | $16.5M | Buy |
+853,900
| New | +$16.5M | ﹤0.01% | 1146 |
|